Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies999
Xencor
Xencor is a clinical-stage biopharmaceutical company that provides protein engineering technology platforms in the biotechnology industry.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
Inimmune
Inimmune is a biotech company developing immunotherapeutics for various diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
ImmunoGen
ImmunoGen is a clinical-stage biotechnology company that develops antibody-based anticancer therapeutics.
Sector
Subsector
Keywords
Location
total rounds
total raised
Morphotek
Morphotek is a biotech company that develops protein and antibody products using gene evolution technology.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds11
Number of Funding Rounds
Money Raised
Their latest funding was raised on 20.03.2019. Their latest investor Nextech Venture. Their latest round Post-IPO Equity
BB Biotech Ventures
BB BIOTECH VENTURES is a healthcare-focused venture capital fund.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors18
Number of lead investors
Number of investors
Nextech Venture
Nextech Venture is a Swiss venture capital firm focusing on precision therapies in oncology.
Sector
Subsector
Location
count Of Investments
Red Abbey Venture Partners
Red Abbey Venture Partners is a life sciences investment firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
CIDC Consultants
CIDC Consultants is a venture capital firm in Taiwan that focuses on production, trade, services, and investments in technology businesses.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Acquisitions2
Raven Biotechnologies acquired by MacroGenics
acquirer
date
type
Raven Biotechnologies
Raven Biotechnologies develops monoclonal antibody therapeutics for cancer treatment.
Sector
Subsector
Keywords
Location
total rounds
total raised
Eliance Biotechnology acquired by MacroGenics
acquirer
date
type
Eliance Biotechnology
Eliance Biotechnology is a vaccine research and discovery company.
Sector
Subsector
Location
People
Founders5
Ruedi Aebersold
Prof. Dr. Ruedi Aebersold (co-founder) is one of the pioneers in the field of proteomics. He is known for developing a series of methods that have found wide application in analytical protein chemistry and proteomics. In 2000 he co-founded the Institute for Systems Biology in Seattle, US, and in 2005 the Institute of Molecular Systems Biology at the ETH Zurich. Ruedi Aebersold also serves on the Scientific Advisory Committees of numerous academic and private sector research organizations and is a member of several editorial boards in the fields of protein science, genomics, and proteomics.
current job
organization founded
Ruedi Aebersold
Jeffrey V. Ravetch
Dr. Jeffrey Ravetch is a Co-Founder & serves as an Advisor at Nuvig Therapeutics. Dr. Ravetch is a Co-Founder of MacroGenics. He also serves as a Venture Partner at Catalio Capital Management. He received his B.S. in Molecular Biophysics and Biochemistry from Yale University in 1973, a Ph.D. from Rockefeller University - Cornell Medical School in 1978, and his M.D. from Cornell University Medical College.
current job
organization founded
Jeffrey V. Ravetch
Leroy Hood
Leroy Hood is currently President of the Institute for Systems Biology. His research has focused on the study of molecular immunology, biotechnology, and genomics. His professional career began at the California Institute of Technology where he and his colleagues pioneered four instruments—the DNA gene sequencer and synthesizer, and the protein synthesizer and sequencer—which comprise the technological foundation for contemporary molecular biology. In particular, the DNA sequencer has revolutionized genomics by allowing the rapid, automated sequencing of DNA, which played a crucial role in contributing to the successful mapping of the human genome during the 1990s. In 1992, Hood moved to the University of Washington as founder and Chairman of the cross-disciplinary Department of Molecular Biotechnology. In 2000, he co-founded the Institute for Systems Biology in Seattle, Washington to pioneer systems approaches to biology and medicine. Hood is a member of the National Academy of Sciences, the American Philosophical Society, the American Association of Arts and Sciences, and the Institute of Medicine. He has also played a role in founding numerous biotechnology companies, including Amgen, Applied Biosystems, Systemix, Darwin, and Rosetta. Hood received an M.D. from Johns Hopkins School of Medicine and a Ph.D. in Biochemistry from the California Institute of Technology. He has published more than 600 peer-reviewed papers, has 14 issued patents, and has co-authored textbooks in biochemistry, immunology, molecular biology, and genetics.
current job
Leroy Hood
Scott Koenig
Dr. Scott Koenig has been President and Chief Executive Officer of MacroGenics since September 2001. Prior to joining MacroGenics, he served as Senior Vice President of Research at MedImmune, Inc., where he participated in the selection and maturation of the company's product pipeline for 11 years. From 1984 to 1990, he worked in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health, where he investigated the immune response to retroviruses and studied the pathogenesis of AIDS. Currently, he is Chairman of the Board of Directors at Applied Genetic Therapy Corporation, and serves as a Board member of MacroGenics, BIO, Children’s Research Institute of Children’s National Medical Center, the AERAS Clinical and Epidemiological Technical Advisory Board, and the Cornell University Council.
current job
organization founded
Scott Koenig
Employee Profiles97
Julie Whittaker
Senior talent acquisition specialist
Brian Ghuzzi
Associate director, manufacturing sciences and technology
Dominick Southmayd
Director of engineering and facilities
Harish Krishnaswamy
Sr. Director Of Business Development
Activity
Recent News12
The graph reveals the ratio (%) of positive news articles in a chosen time range